NOBLADS – External Validation of a Risk Scoring System for Severe Acute Lower Gastrointestinal Bleeding

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Mariana Brito ◽  
Marta Patita ◽  
Gonçalo Nunes ◽  
Manuela Canhoto ◽  
Jorge Fonseca
PLoS ONE ◽  
2018 ◽  
Vol 13 (4) ◽  
pp. e0196514 ◽  
Author(s):  
Tomonori Aoki ◽  
Atsuo Yamada ◽  
Naoyoshi Nagata ◽  
Ryota Niikura ◽  
Yoshihiro Hirata ◽  
...  

2016 ◽  
Vol 14 (11) ◽  
pp. 1562-1570.e2 ◽  
Author(s):  
Tomonori Aoki ◽  
Naoyoshi Nagata ◽  
Takuro Shimbo ◽  
Ryota Niikura ◽  
Toshiyuki Sakurai ◽  
...  

2021 ◽  
Author(s):  
Wen Luo ◽  
Hao Wen ◽  
Shuqi Ge ◽  
Chunzhi Tang ◽  
Xiufeng Liu ◽  
...  

Abstract Objective: We aim to develop a sex-specific risk scoring system for predicting cognitive normal (CN) to mild cognitive impairment (MCI), abbreviated SRSS-CNMCI, to provide a reliable tool for the prevention of MCI.Methods: Participants aged 61-90 years old with a baseline diagnosis of CN and an endpoint diagnosis of MCI were screened from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database with at least one follow-up. Multivariable Cox proportional hazards models were used to identify risk factors associated with conversion from CN to MCI and to build risk scoring systems for male and female groups. Receiver operating characteristic (ROC) curve analysis was applied to determine the risk probability cutoff point corresponding to the optimal prediction effect. We ran an external validation of the discrimination and calibration based on the Harvard Aging Brain Study (HABS) database.Results: A total of 471 participants, including 240 women (51%) and 231 men (49%), aged 61 to 90 years, were included in the study cohort for subsequent primary analysis. The final multivariable models and the risk scoring systems for females and males included age, APOE ε4, Mini-Mental State Examination (MMSE) and Clinical Dementia Rating (CDR). The scoring systems for females and males revealed C statistics of 0.902 (95% CI 0.840-0.963) and 0.911 (95% CI 0.863-0.959), respectively, as measures of discrimination. The cutoff point of high and low risk was 33% in females, and more than 33% was considered high risk, while more than 9% was considered high risk for males. The external validation effect of the scoring systems was good: C statistic 0.950 for the females and C statistic 0.965 for the males. Conclusions: Our parsimonious model accurately predicts conversion from CN to MCI with four risk factors and can be used as a predictive tool for the prevention of MCI.


2020 ◽  
Author(s):  
Eun Jung Kwon ◽  
Mihyang Ha ◽  
Jeon Yeob Jang ◽  
Yun Hak Kim

Human papillomavirus (HPV) infects squamous epithelium and is a major cause of cervical cancer (CC) and a subset of head and neck cancer (HNC). Virus-induced tumourigenesis, molecular alterations, and related prognostic markers are expected to be similar between the two cancers, but they remain poorly understood. We present integrated molecular analysis of HPV-associated tumours from TCGA and GEO databases and identify prognostic biomarkers. Analysis of gene expression profiles identified common upregulated genes and pathways of DNA replication and repair in the HPV-associated tumours. We established 34 prognostic gene signatures with universal cut-off value in TCGA-CC using Elastic Net Cox regression analysis. We were externally validated in TCGA-HNC and several GEO datasets, and demonstrated prognostic power in HPV-associated HNC, but not in HPV-negative cancers. The HPV-related prognostic and predictive indicator did not discriminate other cancers, except bladder urothelial carcinoma. These results identify and completely validate a highly selective prognostic system and its cross-usefulness in HPV-associated cancers, regardless of the tumour’s anatomical subsite. Importance Persistent infection with high-risk HPV interferes with cell function regulation and causes cell mutations, which accumulate over the long term and eventually develop into cancer. Results of pathway enrichment analysis presumably showed that accumulation of intracellular damage during the chronic HPV infected state. We used highly advanced statistical method to identify the most appropriate genes and coefficients and developed the HPPI risk scoring system. We applied same cut-off value to training and validation sets and demonstrated good prognostic performance in both data sets, and confirmed a consistent trend in external validation. Moreover, HPPI presented significant validation result of bladder cancer suspected to be related to HPV. This suggested that our risk scoring system based on the prognostic gene signature could play an important role in the development of treatment strategies for patients with HPV-related cancer.


Sign in / Sign up

Export Citation Format

Share Document